Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495632 · ClinicalTrials.gov registry record · Phase 4

Scheduled or As Needed Pain Regimen?

A Phase 4 study of Pain, Postoperative, sponsored by Cape Fear Valley Health System.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT06495632 is a Phase 4 study of Pain, Postoperative that is actively recruiting participants, run by Cape Fear Valley Health System. The registered enrollment target is 90 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495632, a Phase 4 study of Pain, Postoperative, is actively recruiting participants, sponsored by Cape Fear Valley Health System.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine feasibility of a randomized controlled trial and estimates of efficacy for pain control of a scheduled pain regimen versus an as needed pain regimen for participants undergoing same day surgery procedures.

Conditions Studied

Interventions

  • DRUG Motrin and narcotic

Study Locations (1)

North Carolina

  • Cape Fear Valley Medical Center - Fayetteville

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-08-01
Est. Completion 2027-07-31
Phase Phase 4

Sponsor

Cape Fear Valley Health System

1 total trials

What the Registry Record Tells You About NCT06495632

The ClinicalTrials.gov registry entry for NCT06495632 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The listed sponsor is Cape Fear Valley Health System, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Motrin and narcotic is the first listed.

NCT06495632 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06495632 about?

NCT06495632 is a clinical study titled "Scheduled or As Needed Pain Regimen?". The aim of this study is to determine feasibility of a randomized controlled trial and estimates of efficacy for pain control of a scheduled pain regimen versus an as needed pain regimen for participants undergoing same day surgery procedures.

What is the current status of trial NCT06495632?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2024-08-01. Estimated completion is 2027-07-31.

What conditions does trial NCT06495632 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT06495632?

The interventions under investigation include: Motrin and narcotic (DRUG).

Who is sponsoring clinical trial NCT06495632?

This trial is sponsored by Cape Fear Valley Health System, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495632 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.